French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...

US pharma major Eli Lilly plans to bolster its domestic medicine production across therapeutic areas by building four new ...

The US Food and Drug Administration (FDA) has accepted for review Regeneron Pharmaceuticals’ resubmission of the Biologics ...

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s ...

Danish dermatology specialist LEO Pharma has announced results showing a strong performance in 2024, with both sales growth ...

California-based biotech Eikon Therapeutics today announced the initial closing of a $350.7 million Series D financing. Since ...

Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a royalty financing agreement with Castle Creek Biosciences, providing ...

Shares of Sweden’s immune-oncology firm Alligator Bioscience were up almost 160% at 0.11 kronor by early afternoon today, ...

Candel Therapeutics (Nasdaq: CADL) has released final data from a Phase II trial of its investigational immunotherapy, ...

Swiss biotech company Idorsia has revised its collaboration terms with Viatris, reducing its financial commitment to the ...

Repare Therapeutics is set to cut approximately 75% of its workforce as part of a restructuring plan aimed at extending its ...

Neurodevelopmental disorders company GRIN Therapeutics, an affiliate of the Blackstone Life Sciences portfolio company ...